Ontogenic expression of human carboxylesterase-2 and cytochrome P450 3A4 in liver and duodenum: Postnatal surge and organ-dependent regulation
Human carboxylesterase-2 (CES2) and cytochrome P450 3A4 (CYP3A4) are two major drug metabolizing enzymes that play critical roles in hydrolytic and oxidative biotransformation, respectively. They share substrates but may have opposite effect on therapeutic potential such as the metabolism of the ant...
Saved in:
Published in | Toxicology (Amsterdam) Vol. 330; pp. 55 - 61 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Ireland
Elsevier B.V
01.04.2015
Elsevier Ireland Ltd |
Subjects | |
Online Access | Get full text |
ISSN | 0300-483X 1879-3185 1879-3185 |
DOI | 10.1016/j.tox.2015.02.007 |
Cover
Abstract | Human carboxylesterase-2 (CES2) and cytochrome P450 3A4 (CYP3A4) are two major drug metabolizing enzymes that play critical roles in hydrolytic and oxidative biotransformation, respectively. They share substrates but may have opposite effect on therapeutic potential such as the metabolism of the anticancer prodrug irinotecan. Both CES2 and CYP3A4 are expressed in the liver and the gastrointestinal tract. This study was conducted to determine whether CES2 and CYP3A4 are expressed under developmental regulation and whether the regulation occurs differentially between the liver and duodenum. A large number of tissues (112) were collected with majority of them from donors at 1–198 days of age. In addition, multi-sampling (liver, duodenum and jejunum) was performed in some donors. The expression was determined at mRNA and protein levels. In the liver, CES2 and CYP3A4 mRNA exhibited a postnatal surge (1 versus 2 months of age) by 2.7 and 29 fold, respectively. CYP3A4 but not CES2 mRNA in certain pediatric groups reached or even exceeded the adult level. The duodenal samples, on the other hand, showed a gene-specific expression pattern at mRNA level. CES2 mRNA increased with age but the opposite was true with CYP3A4 mRNA. The levels of CES2 and CYP3A4 protein, on the other hand, increased with age in both liver and duodenum. The multi-sampling study demonstrated significant correlation of CES2 expression between the duodenum and jejunum. However, neither duodenal nor jejunal expression correlated with hepatic expression of CES2. These findings establish that developmental regulation occurs in a gene and organ-dependent manner. |
---|---|
AbstractList | Human carboxylesterase-2 (CES2) and cytochrome P450 3A4 (CYP3A4) are two major drug metabolizing enzymes that play critical roles in hydrolytic and oxidative biotransformation, respectively. They share substrates but may have opposite effect on therapeutic potential such as the metabolism of the anticancer prodrug irinotecan. Both CES2 and CYP3A4 are expressed in the liver and the gastrointestinal tract. This study was conducted to determine whether CES2 and CYP3A4 are expressed under developmental regulation and whether the regulation occurs differentially between the liver and duodenum. A large number of tissues (112) were collected with majority of them from donors at 1–198 days of age. In addition, multi-sampling (liver, duodenum and jejunum) was performed in some donors. The expression was determined at mRNA and protein levels. In the liver, CES2 and CYP3A4 mRNA exhibited a postnatal surge (1 versus 2 months of age) by 2.7 and 29 fold, respectively. CYP3A4 but not CES2 mRNA in certain pediatric groups reached or even exceeded the adult level. The duodenal samples, on the other hand, showed a gene-specific expression pattern at mRNA level. CES2 mRNA increased with age but the opposite was true with CYP3A4 mRNA. The levels of CES2 and CYP3A4 protein, on the other hand, increased with age in both liver and duodenum. The multi-sampling study demonstrated significant correlation of CES2 expression between the duodenum and jejunum. However, neither duodenal nor jejunal expression correlated with hepatic expression of CES2. These findings establish that developmental regulation occurs in a gene and organ-dependent manner. Abstract Human carboxylesterase-2 (CES2) and cytochrome P450 3A4 (CYP3A4) are two major drug metabolizing enzymes that play critical roles in hydrolytic and oxidative biotransformation, respectively. They share substrates but may have opposite effect on therapeutic potential such as the metabolism of the anticancer prodrug irinotecan. Both CES2 and CYP3A4 are expressed in the liver and the gastrointestinal tract. This study was conducted to determine whether CES2 and CYP3A4 are expressed under developmental regulation and whether the regulation occurs differentially between the liver and duodenum. A large number of tissues (112) were collected with majority of them from donors at 1–198 days of age. In addition, multi-sampling (liver, duodenum and jejunum) was performed in some donors. The expression was determined at mRNA and protein levels. In the liver, CES2 and CYP3A4 mRNA exhibited a postnatal surge (1 versus 2 months of age) by 2.7 and 29 fold, respectively. CYP3A4 but not CES2 mRNA in certain pediatric groups reached or even exceeded the adult level. The duodenal samples, on the other hand, showed a gene-specific expression pattern at mRNA level. CES2 mRNA increased with age but the opposite was true with CYP3A4 mRNA. The levels of CES2 and CYP3A4 protein, on the other hand, increased with age in both liver and duodenum. The multi-sampling study demonstrated significant correlation of CES2 expression between the duodenum and jejunum. However, neither duodenal nor jejunal expression correlated with hepatic expression of CES2. These findings establish that developmental regulation occurs in a gene and organ-dependent manner. Human carboxylesterase-2 (CES2) and cytochrome P450 3A4 (CYP3A4) are two major drug metabolizing enzymes that play critical roles in hydrolytic and oxidative biotransformation, respectively. They share substrates but may have opposite effect on therapeutic potential such as the metabolism of the anticancer prodrug irinotecan. Both CES2 and CYP3A4 are expressed in the liver and the gastrointestinal tract. This study was conducted to determine whether CES2 and CYP3A4 are expressed under developmental regulation and whether the regulation occurs differentially between the liver and duodenum. A large number of tissues (112) were collected with majority of them from donors at 1-198 days of age. In addition, multi-sampling (liver, duodenum and jejunum) was performed in some donors. The expression was determined at mRNA and protein levels. In the liver, CES2 and CYP3A4 mRNA exhibited a postnatal surge (1 versus 2 months of age) by 2.7 and 29 fold, respectively. CYP3A4 but not CES2 mRNA in certain pediatric groups reached or even exceeded the adult level. The duodenal samples, on the other hand, showed a gene-specific expression pattern at mRNA level. CES2 mRNA increased with age but the opposite was true with CYP3A4 mRNA. The levels of CES2 and CYP3A4 protein, on the other hand, increased with age in both liver and duodenum. The multi-sampling study demonstrated significant correlation of CES2 expression between the duodenum and jejunum. However, neither duodenal nor jejunal expression correlated with hepatic expression of CES2. These findings establish that developmental regulation occurs in a gene and organ-dependent manner.Human carboxylesterase-2 (CES2) and cytochrome P450 3A4 (CYP3A4) are two major drug metabolizing enzymes that play critical roles in hydrolytic and oxidative biotransformation, respectively. They share substrates but may have opposite effect on therapeutic potential such as the metabolism of the anticancer prodrug irinotecan. Both CES2 and CYP3A4 are expressed in the liver and the gastrointestinal tract. This study was conducted to determine whether CES2 and CYP3A4 are expressed under developmental regulation and whether the regulation occurs differentially between the liver and duodenum. A large number of tissues (112) were collected with majority of them from donors at 1-198 days of age. In addition, multi-sampling (liver, duodenum and jejunum) was performed in some donors. The expression was determined at mRNA and protein levels. In the liver, CES2 and CYP3A4 mRNA exhibited a postnatal surge (1 versus 2 months of age) by 2.7 and 29 fold, respectively. CYP3A4 but not CES2 mRNA in certain pediatric groups reached or even exceeded the adult level. The duodenal samples, on the other hand, showed a gene-specific expression pattern at mRNA level. CES2 mRNA increased with age but the opposite was true with CYP3A4 mRNA. The levels of CES2 and CYP3A4 protein, on the other hand, increased with age in both liver and duodenum. The multi-sampling study demonstrated significant correlation of CES2 expression between the duodenum and jejunum. However, neither duodenal nor jejunal expression correlated with hepatic expression of CES2. These findings establish that developmental regulation occurs in a gene and organ-dependent manner. |
Author | Chen, Yi-Tzai Trzoss, Lynnie Yan, Bingfang Yang, Dongfang |
Author_xml | – sequence: 1 givenname: Yi-Tzai surname: Chen fullname: Chen, Yi-Tzai – sequence: 2 givenname: Lynnie surname: Trzoss fullname: Trzoss, Lynnie – sequence: 3 givenname: Dongfang surname: Yang fullname: Yang, Dongfang – sequence: 4 givenname: Bingfang surname: Yan fullname: Yan, Bingfang email: byan@uri.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25724353$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkk9rFDEYhwep2G31A3iRHL3Mmn-TmVEQSqlVKLSggreQSd7ZZp1J1iRTdr-En7nZ3fZSsOsphzy_N-T9PSfFkfMOiuItwXOCifiwnCe_nlNMqjmmc4zrF8WMNHVbMtJUR8UMM4xL3rBfx8VJjEuMMWVcvCqOaVVTzio2K_5eu-QX4KxGsF4FiNF6h3yPbqdROaRV6Px6M0BMEFSEkiLlDNKb5PVt8COgG15hxM44sg4N9g7CDjCTN-Cm8SO68TE5ldSA4hQWsLv1YaFcaWAFLlMJBVhMg0r55dfFy14NEd48nKfFzy8XP86_llfXl9_Oz65KLYRIOUpYJXrCOFa0x8bURvRMdQR3VOFWtbTqSM06zRmnHVNAGl33rDNtR0kFNTst3u_nroL_M-XfydFGDcOgHPgpStJwwQgReXkH0brGjNSt4P-BMtowiik9jArBSUuxEBl994BO3QhGroIdVdjIxxIzUO8BHXyMAXqpbdqtMwVlB0mw3OoilzLrIre6SExl1iUnyZPk4_DnMp_2Gcj93FkIMmoLToOxAXSSxttn05-fpPVgs31q-A0biEs_BZeLl0TGHJDftwpvDSZVtpezbR3tvwccePweWDoABg |
CitedBy_id | crossref_primary_10_1002_hep_31250 crossref_primary_10_1016_j_bmc_2024_117938 crossref_primary_10_1007_s00280_017_3447_x crossref_primary_10_1111_fcp_12889 crossref_primary_10_1093_toxsci_kfz237 crossref_primary_10_1124_dmd_118_084418 crossref_primary_10_3390_pharmaceutics15092231 crossref_primary_10_2903_j_efsa_2020_6153 crossref_primary_10_1124_dmd_116_072652 crossref_primary_10_1124_dmd_121_000559 crossref_primary_10_1016_j_addr_2021_03_011 crossref_primary_10_1016_j_ejpb_2023_08_011 crossref_primary_10_1124_dmd_115_068957 crossref_primary_10_1002_bdd_2052 crossref_primary_10_1080_17425255_2024_2348491 crossref_primary_10_2174_1389200224666221212143904 crossref_primary_10_1002_cpt_3354 crossref_primary_10_2174_1389200219666180821094502 crossref_primary_10_1248_bpb_b17_00880 crossref_primary_10_3390_pharmaceutics13060887 crossref_primary_10_1111_bcp_14111 crossref_primary_10_3390_pharmaceutics15112579 crossref_primary_10_1016_j_apsb_2016_07_012 crossref_primary_10_1111_epi_16746 crossref_primary_10_1016_j_canlet_2016_04_041 crossref_primary_10_1002_jcph_1284 crossref_primary_10_1016_j_ijpharm_2024_123962 crossref_primary_10_3390_pharmaceutics15122765 crossref_primary_10_1016_j_ntt_2021_106983 crossref_primary_10_1002_psp4_13192 crossref_primary_10_1177_1091581817721675 crossref_primary_10_1248_yakushi_18_00228 |
Cites_doi | 10.1634/theoncologist.2010-0260 10.2174/0929867033456855 10.1186/1472-6939-14-55 10.3389/fgene.2013.00012 10.1006/taap.1999.8693 10.1124/dmd.112.050211 10.1016/S0021-9258(18)43935-X 10.1002/jcph.161 10.1074/jbc.M709382200 10.3109/00498254.2012.694493 10.1124/dmd.109.028209 10.2174/092986609789071324 10.1124/dmd.105.007807 10.1016/j.bcp.2008.10.005 10.1124/jpet.104.074971 10.1124/dmd.113.054635 10.1124/dmd.105.005611 10.1006/abbi.1995.1121 10.1006/abbi.1994.1532 10.1006/taap.1994.1106 10.1124/dmd.105.008672 10.1124/mol.107.036889 10.2337/diab.46.8.1319 10.1093/infdis/jiq145 10.1016/S0090-9556(25)08432-6 10.1016/j.bbalip.2007.01.007 10.1016/j.ijpharm.2012.05.079 10.1016/j.bcp.2012.04.002 10.1124/dmd.30.5.541 10.1016/S0300-483X(01)00416-4 10.1371/journal.pone.0082562 10.1016/j.tiv.2005.06.045 10.1042/BJ20070613 10.1002/med.20014 10.1111/j.1740-8261.2009.01626.x 10.1038/clpt.2013.220 10.1016/j.cmet.2010.02.001 10.1016/S0090-9556(24)15127-6 10.1124/dmd.110.035956 10.1124/dmd.109.027680 |
ContentType | Journal Article |
Copyright | 2015 Elsevier Ireland Ltd Elsevier Ireland Ltd 2015 Copyright © 2015 Elsevier Ireland Ltd. All rights reserved. |
Copyright_xml | – notice: 2015 Elsevier Ireland Ltd – notice: Elsevier Ireland Ltd – notice: 2015 – notice: Copyright © 2015 Elsevier Ireland Ltd. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7U7 C1K 8FD FR3 KR7 7S9 L.6 |
DOI | 10.1016/j.tox.2015.02.007 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Toxicology Abstracts Environmental Sciences and Pollution Management Technology Research Database Engineering Research Database Civil Engineering Abstracts AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Toxicology Abstracts Environmental Sciences and Pollution Management Technology Research Database Civil Engineering Abstracts Engineering Research Database AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA MEDLINE - Academic MEDLINE Technology Research Database Toxicology Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1879-3185 |
EndPage | 61 |
ExternalDocumentID | 25724353 10_1016_j_tox_2015_02_007 S0300483X15000438 1_s2_0_S0300483X15000438 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: GM61988 – fundername: NIEHS NIH HHS grantid: R29 ES007965 – fundername: NCCIH NIH HHS grantid: R15 AT007705 – fundername: NIEHS NIH HHS grantid: ES07965 – fundername: NIGMS NIH HHS grantid: R01 GM061988 – fundername: NIEHS NIH HHS grantid: R01 ES007965 – fundername: NCCIH NIH HHS grantid: AT007705 |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO AAYWO ABFRF ABFYP ABJNI ABLST ABMAC ABOCM ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ACVFH ADBBV ADCNI ADEZE AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AHEUO AIEXJ AIIUN AIKHN AITUG AJUYK AKBMS AKIFW AKRWK AKYEP ALCLG ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU AXJTR BKOJK BLECG BLXMC CS3 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W KCYFY KOM M34 M41 MO0 N9A O-L O9- OAUVE OB~ OGGZJ OM0 OZT P-8 P-9 P2P PC. Q38 ROL RPZ SCC SDF SDG SDP SES SPCBC SSJ SSP SSZ T5K WH7 Z5R ~G- .GJ 29Q 3O- 53G AACTN AAQXK ABEFU ABFNM ABWVN ABXDB ACRPL ADMUD ADNMO AFCTW AFFNX AFJKZ AFKWA AHHHB AJOXV AMFUW ASPBG AVWKF AZFZN FEDTE FGOYB G-2 HMT HVGLF HZ~ R2- SEW SPT WUQ XPP Y6R ZGI ZXP AAIAV AATCM ABYKQ AJBFU EFLBG AAYXX AGQPQ AIGII APXCP CITATION CGR CUY CVF ECM EIF NPM SSH 7X8 7U7 C1K 8FD FR3 KR7 7S9 L.6 |
ID | FETCH-LOGICAL-c666t-de1356f1340a2f0dd7d6f3ab10b2a09a925b173bc4342b3ae18c7f3bd9b215e73 |
IEDL.DBID | AIKHN |
ISSN | 0300-483X 1879-3185 |
IngestDate | Thu Sep 04 18:05:33 EDT 2025 Thu Sep 04 18:57:15 EDT 2025 Thu Sep 04 20:56:15 EDT 2025 Fri Sep 05 06:59:50 EDT 2025 Thu Apr 03 07:08:23 EDT 2025 Thu Apr 24 22:53:48 EDT 2025 Wed Sep 10 05:18:23 EDT 2025 Fri Feb 23 02:25:34 EST 2024 Sun Feb 23 10:19:01 EST 2025 Tue Aug 26 16:33:59 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | PBS GI Toxicology Cytochrome P450 Drug metabolism Ontogeny CYP3A4 PPARα GAPDH RT-qPCR CES2 Carboxylesterases reverse transcription-quantitative polymerase chain reaction carboxylesterase-2 peroxisome proliferator-activated receptor-α cytochrome P450 3A4 gastrointestinal phosphate buffered saline glyceradehyde-3-phosphate dehydrogenase |
Language | English |
License | Copyright © 2015 Elsevier Ireland Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c666t-de1356f1340a2f0dd7d6f3ab10b2a09a925b173bc4342b3ae18c7f3bd9b215e73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/4496585 |
PMID | 25724353 |
PQID | 1664192066 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1846311648 proquest_miscellaneous_1770317964 proquest_miscellaneous_1732832022 proquest_miscellaneous_1664192066 pubmed_primary_25724353 crossref_citationtrail_10_1016_j_tox_2015_02_007 crossref_primary_10_1016_j_tox_2015_02_007 elsevier_sciencedirect_doi_10_1016_j_tox_2015_02_007 elsevier_clinicalkeyesjournals_1_s2_0_S0300483X15000438 elsevier_clinicalkey_doi_10_1016_j_tox_2015_02_007 |
PublicationCentury | 2000 |
PublicationDate | 2015-04-01 |
PublicationDateYYYYMMDD | 2015-04-01 |
PublicationDate_xml | – month: 04 year: 2015 text: 2015-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Ireland |
PublicationPlace_xml | – name: Ireland |
PublicationTitle | Toxicology (Amsterdam) |
PublicationTitleAlternate | Toxicology |
PublicationYear | 2015 |
Publisher | Elsevier B.V Elsevier Ireland Ltd |
Publisher_xml | – name: Elsevier B.V – name: Elsevier Ireland Ltd |
References | Takagi, Nakajima, Mohri, Yokoi (bib0150) 2008; 283 Liu, Olivier, Pope (bib0055) 1999; 158 Pearce, Gotschall, Kearns, Leeder (bib0090) 2001; 29 Zancanella, Giantin, Lopparelli, Nebbia, Dacasto (bib0200) 2012; 42 Sanghani, Sanghani, Schiel, Bosron (bib0110) 2009; 16 Hines (bib0030) 2013; 452 Schleidgen, Klingler, Bertram, Rogowski, Marckmann (bib0115) 2013; 14 Yan, Yang, Brady, Parkinson (bib0170) 1994; 269 Lewis (bib0050) 2003; 10 Deenen, Cats, Beijnen, Schellens (bib0015) 2011; 16 Xie, Yang, Liu, Xue, Yan (bib0165) 2002; 30 Morgan, Yan, Greenway, Parkinson (bib0070) 1994; 315 Hosokawa, Hirata, Nakata, Suga, Satoh (bib0040) 1994; 22 Yan (bib0180) 2012 Yang, Pearce, Wang, Roger, Wan, Yan (bib0190) 2009; 77 Fakhoury, Litalien, Medard, Cavé, Ezzahir, Peuchmaur, Jacqz-Aigrain (bib0020) 2005; 33 Patel, Parker, Yang, Zhang (bib0085) 2013; 10 Paine, Hart, Ludington, Haining, Rettie, Zeldin (bib0075) 2006; 34 Yang, Shi, Yang, Song, Yan (bib0185) 2007; 72 Poole, Bridgers, Alexson, Corton (bib0100) 2001; 165 Klein, Zanger (bib0045) 2013; 4 Shi, Yang, Prinssen, Davies, Yan (bib0125) 2011; 203 Preissner, Hoffmann, Preissner, Dunkel, Gewiess, Preissner (bib0105) 2013; 8 Yan, Yang, Brady, Parkinson (bib0175) 1995; 316 Liu, Yang, Song, Deng, Yan (bib0060) 2008; 409 Peng, Cui, Yoo, Gunewardena, Lu, Klaassen, Zhong (bib0095) 2013; 41 Wu, Yan, Humerickhouse, Dolan (bib0155) 2002; 8 Auboeuf, Rieusset, Fajas, Vallier, Frering, Riou, Staels, Auwerx, Laville, Vidal (bib0010) 1997; 46 Zhu, Song, Zhang, Matoney, LeCluyse, Yan (bib0210) 2000; 28 Hagihara, Kazui, Ikenaga, Nanba, Fusegawa, Izumi, Ikeda, Kurihara (bib0025) 2011; 39 You (bib0195) 2004; 24 Stander, Wagner, Goddard, Kirberger (bib0140) 2010; 51 Song, Li, Liu, Mukundan, Yan (bib0135) 2005; 312 Zoete, Grosdidier, Michielin (bib0220) 2007; 1771 Smith, Figg, Sparreboom (bib0130) 2006; 20 Stoll, Burhenne, Lausecker, Weiss, Thomsen, Haefeli, Mikus (bib0145) 2013; 53 Hondares, Rosell, Gonzalez, Giralt, Iglesias, Villarroya (bib0035) 2010; 11 Pan, Gao, Yu (bib0080) 2009; 37 Sheets, Doherty, Law, Reiter, Crofton (bib0120) 1994; 126 Zanger, Klein, Thomas, Rieger, Tremmel, Kandel, Klein, Magdy (bib0205) 2014; 95 Anand, Kim, Padilla, Muralidhara, Kim, Fisher, Bruckner (bib0005) 2006; 34 Zhu, Appel, Jiang, Markowitz (bib0215) 2009; 37 Lu, Gunewardena, Cui, Yoo, Zhong, Klaassen (bib0065) 2013; 41 Xiao, Chen, Yang, Yan (bib0160) 2012; 84 Zoete (10.1016/j.tox.2015.02.007_bib0220) 2007; 1771 Lu (10.1016/j.tox.2015.02.007_bib0065) 2013; 41 Xiao (10.1016/j.tox.2015.02.007_bib0160) 2012; 84 Zhu (10.1016/j.tox.2015.02.007_bib0210) 2000; 28 Pearce (10.1016/j.tox.2015.02.007_bib0090) 2001; 29 Yan (10.1016/j.tox.2015.02.007_bib0180) 2012 Stander (10.1016/j.tox.2015.02.007_bib0140) 2010; 51 Xie (10.1016/j.tox.2015.02.007_bib0165) 2002; 30 Zancanella (10.1016/j.tox.2015.02.007_bib0200) 2012; 42 Yang (10.1016/j.tox.2015.02.007_bib0185) 2007; 72 Zhu (10.1016/j.tox.2015.02.007_bib0215) 2009; 37 Deenen (10.1016/j.tox.2015.02.007_bib0015) 2011; 16 Takagi (10.1016/j.tox.2015.02.007_bib0150) 2008; 283 Pan (10.1016/j.tox.2015.02.007_bib0080) 2009; 37 Wu (10.1016/j.tox.2015.02.007_bib0155) 2002; 8 Poole (10.1016/j.tox.2015.02.007_bib0100) 2001; 165 You (10.1016/j.tox.2015.02.007_bib0195) 2004; 24 Stoll (10.1016/j.tox.2015.02.007_bib0145) 2013; 53 Paine (10.1016/j.tox.2015.02.007_bib0075) 2006; 34 Liu (10.1016/j.tox.2015.02.007_bib0055) 1999; 158 Hines (10.1016/j.tox.2015.02.007_bib0030) 2013; 452 Hosokawa (10.1016/j.tox.2015.02.007_bib0040) 1994; 22 Peng (10.1016/j.tox.2015.02.007_bib0095) 2013; 41 Song (10.1016/j.tox.2015.02.007_bib0135) 2005; 312 Smith (10.1016/j.tox.2015.02.007_bib0130) 2006; 20 Lewis (10.1016/j.tox.2015.02.007_bib0050) 2003; 10 Schleidgen (10.1016/j.tox.2015.02.007_bib0115) 2013; 14 Sanghani (10.1016/j.tox.2015.02.007_bib0110) 2009; 16 Patel (10.1016/j.tox.2015.02.007_bib0085) 2013; 10 Preissner (10.1016/j.tox.2015.02.007_bib0105) 2013; 8 Auboeuf (10.1016/j.tox.2015.02.007_bib0010) 1997; 46 Anand (10.1016/j.tox.2015.02.007_bib0005) 2006; 34 Yan (10.1016/j.tox.2015.02.007_bib0170) 1994; 269 Yang (10.1016/j.tox.2015.02.007_bib0190) 2009; 77 Sheets (10.1016/j.tox.2015.02.007_bib0120) 1994; 126 Liu (10.1016/j.tox.2015.02.007_bib0060) 2008; 409 Shi (10.1016/j.tox.2015.02.007_bib0125) 2011; 203 Yan (10.1016/j.tox.2015.02.007_bib0175) 1995; 316 Klein (10.1016/j.tox.2015.02.007_bib0045) 2013; 4 Zanger (10.1016/j.tox.2015.02.007_bib0205) 2014; 95 Fakhoury (10.1016/j.tox.2015.02.007_bib0020) 2005; 33 Morgan (10.1016/j.tox.2015.02.007_bib0070) 1994; 315 Hondares (10.1016/j.tox.2015.02.007_bib0035) 2010; 11 Hagihara (10.1016/j.tox.2015.02.007_bib0025) 2011; 39 12171903 - Clin Cancer Res. 2002 Aug;8(8):2696-700 23939663 - J Clin Pharmacol. 2013 Nov;53(11):1199-204 11950785 - Drug Metab Dispos. 2002 May;30(5):541-7 18983829 - Biochem Pharmacol. 2009 Jan 15;77(2):238-47 20166399 - Vet Radiol Ultrasound. 2010 Jan-Feb;51(1):75-8 15367577 - J Pharmacol Exp Ther. 2005 Feb;312(2):571-82 22766445 - Int J Pharm. 2013 Aug 16;452(1-2):3-7 9231657 - Diabetes. 1997 Aug;46(8):1319-27 11717173 - Drug Metab Dispos. 2001 Dec;29(12):1548-54 24340040 - PLoS One. 2013;8(12):e82562 7986099 - Arch Biochem Biophys. 1994 Dec;315(2):513-26 21189331 - Drug Metab Dispos. 2011 Apr;39(4):565-70 7961958 - J Biol Chem. 1994 Nov 25;269(47):29688-96 23382457 - Drug Metab Dispos. 2013 Apr;41(4):844-57 11522369 - Toxicology. 2001 Aug 28;165(2-3):109-19 20197053 - Cell Metab. 2010 Mar 3;11(3):206-12 18268015 - J Biol Chem. 2008 Apr 11;283(15):9674-80 15250040 - Med Res Rev. 2004 Nov;24(6):762-74 23444277 - Front Genet. 2013 Feb 25;4:12 21402544 - J Infect Dis. 2011 Apr 1;203(7):937-42 10406933 - Toxicol Appl Pharmacol. 1999 Jul 15;158(2):186-96 7864649 - Arch Biochem Biophys. 1995 Feb 1;316(2):899-908 24359531 - BMC Med Ethics. 2013;14:55 17537833 - Mol Pharmacol. 2007 Sep;72(3):686-94 17317294 - Biochim Biophys Acta. 2007 Aug;1771(8):915-25 16271446 - Toxicol In Vitro. 2006 Mar;20(2):163-75 24196843 - Clin Pharmacol Ther. 2014 Mar;95(3):258-61 16467132 - Drug Metab Dispos. 2006 May;34(5):880-6 1714639 - Toxicology. 1991;68(1):51-61 22513142 - Biochem Pharmacol. 2012 Jul 15;84(2):232-9 22694178 - Xenobiotica. 2012 Nov;42(11):1096-109 12871098 - Curr Med Chem. 2003 Oct;10(19):1955-72 16049125 - Drug Metab Dispos. 2005 Nov;33(11):1603-7 21659608 - Oncologist. 2011;16(7):992-1005 7895606 - Drug Metab Dispos. 1994 Nov-Dec;22(6):889-94 16326812 - Drug Metab Dispos. 2006 Mar;34(3):389-97 10640517 - Drug Metab Dispos. 2000 Feb;28(2):186-91 8184428 - Toxicol Appl Pharmacol. 1994 May;126(1):186-90 24080161 - Drug Metab Dispos. 2013 Dec;41(12):2175-86 19508181 - Protein Pept Lett. 2009;16(10):1207-14 19581388 - Drug Metab Dispos. 2009 Oct;37(10):2112-7 24349831 - Cancer Biol Med. 2013 Dec;10(4):214-20 19487248 - Drug Metab Dispos. 2009 Sep;37(9):1819-25 17764444 - Biochem J. 2008 Jan 1;409(1):243-50 |
References_xml | – volume: 8 start-page: e82562 year: 2013 ident: bib0105 article-title: Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy publication-title: PLoS One – volume: 33 start-page: 1603 year: 2005 end-page: 1607 ident: bib0020 article-title: Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age publication-title: Drug Metab. Dispos. – volume: 41 start-page: 2175 year: 2013 end-page: 2186 ident: bib0095 article-title: RNA-sequencing quantification of hepatic ontogeny of phase-I enzymes in mice publication-title: Drug Metab. Dispos. – volume: 51 start-page: 75 year: 2010 end-page: 78 ident: bib0140 article-title: Normal canine pediatric gastrointestinal ultrasonography publication-title: Vet. Radiol. Ultrasound – volume: 203 start-page: 937 year: 2011 end-page: 942 ident: bib0125 article-title: Surge in expression of carboxylesterase-1 during the post-natal stage enables a rapid gain of the capacity to activate the anti-influenza prodrug oseltamivir publication-title: J. Infect. Dis. – volume: 77 start-page: 238 year: 2009 end-page: 247 ident: bib0190 article-title: Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin publication-title: Biochem. Pharmacol. – volume: 28 start-page: 186 year: 2000 end-page: 191 ident: bib0210 article-title: Dexamethasone differentially regulates expression of carboxylesterase genes in humans and rats publication-title: Drug Metab. Dispos. – volume: 8 start-page: 2696 year: 2002 end-page: 2700 ident: bib0155 article-title: Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells publication-title: Clin. Cancer Res. – volume: 22 start-page: 889 year: 1994 end-page: 894 ident: bib0040 article-title: Species differences in the induction of hepatic microsomal carboxylesterases caused by dietary exposure to di(2-ethylhexyl) phthalate a peroxisome proliferator publication-title: Drug Metab. Dispos. – volume: 158 start-page: 186 year: 1999 end-page: 196 ident: bib0055 article-title: Comparative neurochemical effects of repeated methyl parathion or chlorpyrifos exposures in neonatal and adult rats publication-title: Toxicol. Appl. Pharmacol. – volume: 11 start-page: 206 year: 2010 end-page: 212 ident: bib0035 article-title: Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat publication-title: Cell Metab. – volume: 24 start-page: 762 year: 2004 end-page: 774 ident: bib0195 article-title: Towards an understanding of organic anion transporters: structure-function relationships publication-title: Med. Res. Rev. – volume: 37 start-page: 2112 year: 2009 end-page: 2117 ident: bib0080 article-title: MicroRNAs regulate CYP3A4 expression via direct and indirect targeting publication-title: Drug Metab. Dispos. – volume: 95 start-page: 258 year: 2014 end-page: 261 ident: bib0205 article-title: Genetics: epigenetics and regulation of drug metabolizing cytochrome P450 enzymes publication-title: Clin. Pharmacol. Ther. – volume: 34 start-page: 389 year: 2006 end-page: 397 ident: bib0005 article-title: Ontogeny of hepatic and plasma metabolism of deltamethrin in vitro: role in age-dependent acute neurotoxicity publication-title: Drug Metab. Dispos. – volume: 4 start-page: 12 year: 2013 ident: bib0045 article-title: Pharmacogenomics of cytochrome P450 3A4: recent progress toward the missing heritability problem publication-title: Front. Genet. – volume: 14 start-page: 55 year: 2013 ident: bib0115 article-title: What is personalized medicine: sharpening a vague term based on a systematic literature review publication-title: BMC Med. Ethics – volume: 315 start-page: 514 year: 1994 end-page: 526 ident: bib0070 article-title: Regulation of two rat liver microsomal carboxylesterase isozymes: species differences, tissue distribution and the effects of age sex and xenobiotic treatment of rats publication-title: Arch. Biochem. Biophys. – volume: 39 start-page: 565 year: 2011 end-page: 570 ident: bib0025 article-title: The intestine as an important contributor to prasugrel active metabolite formation in vivo publication-title: Drug Metab. Dispos. – volume: 16 start-page: 1207 year: 2009 end-page: 1214 ident: bib0110 article-title: Human carboxylesterases: an update on CES1, CES2 and CES3 publication-title: Protein Pept. Lett. – volume: 37 start-page: 1819 year: 2009 end-page: 1825 ident: bib0215 article-title: Age- and sex-related expression and activity of carboxylesterase 1 and 2 in mouse and human liver publication-title: Drug Metab. Dispos. – volume: 41 start-page: 844 year: 2013 end-page: 857 ident: bib0065 article-title: RNA-sequencing quantification of hepatic ontogeny and tissue distribution of mRNAs of phase II enzymes in mice publication-title: Drug Metab. Dispos. – volume: 10 start-page: 214 year: 2013 end-page: 220 ident: bib0085 article-title: Translational genomics in cancer research: converting profiles into personalized cancer medicine publication-title: Cancer Biol. Med. – volume: 30 start-page: 541 year: 2002 end-page: 547 ident: bib0165 article-title: Human and rodent carboxylesterases: immunorelatedness, overlapping substrate specificity, differential sensitivity to serine enzyme inhibitors, and tumor-related expression publication-title: Drug Metab. Dispos. – volume: 53 start-page: 1199 year: 2013 end-page: 1204 ident: bib0145 article-title: Reduced exposure variability of the CYP3A substrate simvastatin by dose individualization to CYP3A activity publication-title: J. Clin. Pharmacol. – volume: 72 start-page: 686 year: 2007 end-page: 694 ident: bib0185 article-title: Interleukin-6 suppresses the expression of carboxylesterases HCE1 and HCE2 through transcriptional repression publication-title: Mol. Pharmacol. – volume: 42 start-page: 1096 year: 2012 end-page: 1109 ident: bib0200 article-title: Constitutive expression and phenobarbital modulation of drug metabolizing enzymes and related nuclear receptors in cattle liver and extra-hepatic tissues publication-title: Xenobiotica – volume: 409 start-page: 243 year: 2008 end-page: 250 ident: bib0060 article-title: The far and distal enhancers in the CYP3A4 gene coordinates the proximal promoter in responding to the pregnane X receptor similarly but differentially to hepatocyte nuclear factor-4α publication-title: Biochem. J. – volume: 34 start-page: 880 year: 2006 end-page: 886 ident: bib0075 article-title: The human intestinal cytochrome P450 pie publication-title: Drug Metab. Dispos. – start-page: 165 year: 2012 end-page: 199 ident: bib0180 article-title: Hydrolytic enzymes publication-title: Metabolism of Drugs and Other Xenobiotics – volume: 29 start-page: 1548 year: 2001 end-page: 1554 ident: bib0090 article-title: Cytochrome P450 Involvement in the biotransformation of cisapride and racemic norcisapride in vitro: differential activity of individual human CYP3A isoforms publication-title: Drug Metab. Dispos. – volume: 10 start-page: 1955 year: 2003 end-page: 1972 ident: bib0050 article-title: Human cytochromes P450 associated with the phase 1 metabolism of drugs and other xenobiotics: a compilation of substrates and inhibitors of the CYP1 CYP2 and CYP3 families publication-title: Curr. Med. Chem. – volume: 165 start-page: 109 year: 2001 end-page: 119 ident: bib0100 article-title: Altered expression of the carboxylesterases ES-4 and ES-10 by peroxisome proliferator chemicals publication-title: Toxicology – volume: 16 start-page: 992 year: 2011 end-page: 1005 ident: bib0015 article-title: Part 3: pharmacogenetic variability in phase II anticancer drug metabolism publication-title: Oncologist – volume: 1771 start-page: 915 year: 2007 end-page: 925 ident: bib0220 article-title: Peroxisome proliferator-activated receptor structures: ligand specificity: molecular switch and interactions with regulators publication-title: Biochim. Biophys. Acta – volume: 46 start-page: 1319 year: 1997 end-page: 1327 ident: bib0010 article-title: Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients publication-title: Diabetes – volume: 126 start-page: 186 year: 1994 end-page: 190 ident: bib0120 article-title: Age-dependent differences in the susceptibility of rats to deltamethrin publication-title: Toxicol. Appl. Pharmacol. – volume: 312 start-page: 571 year: 2005 end-page: 582 ident: bib0135 article-title: Simultaneous substitution of phenylalaine-305 and aspartate-318 of rat PXR by the corresponding human residues abolishes the ability to transactivate the cytochrome P4503A23 promoter publication-title: J. Pharmacol. Exp. Ther. – volume: 316 start-page: 899 year: 1995 end-page: 908 ident: bib0175 article-title: Rat testicular carboxylesterase: cloning sequencing, cellular localization and relationship to liver hydrolase A publication-title: Arch. Biochem. Biophys. – volume: 84 start-page: 232 year: 2012 end-page: 239 ident: bib0160 article-title: Age-related inducibility of carboxylesterases by the antiepileptic agent phenobarbital and implications in drug metabolism and lipid accumulation publication-title: Biochem. Pharmacol. – volume: 20 start-page: 163 year: 2006 end-page: 175 ident: bib0130 article-title: Pharmacogenetics of irinotecan metabolism and transport: an update publication-title: Toxicol. In Vitro – volume: 452 start-page: 3 year: 2013 end-page: 7 ident: bib0030 article-title: Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children publication-title: Int. J. Pharm. – volume: 269 start-page: 29688 year: 1994 end-page: 29696 ident: bib0170 article-title: Rat kidney carboxylesterase: cloning, sequencing, cellular localization and relationship to liver hydrolase B publication-title: J. Biol. Chem. – volume: 283 start-page: 9674 year: 2008 end-page: 9680 ident: bib0150 article-title: Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4 publication-title: J. Biol. Chem. – volume: 16 start-page: 992 year: 2011 ident: 10.1016/j.tox.2015.02.007_bib0015 article-title: Part 3: pharmacogenetic variability in phase II anticancer drug metabolism publication-title: Oncologist doi: 10.1634/theoncologist.2010-0260 – volume: 10 start-page: 1955 year: 2003 ident: 10.1016/j.tox.2015.02.007_bib0050 article-title: Human cytochromes P450 associated with the phase 1 metabolism of drugs and other xenobiotics: a compilation of substrates and inhibitors of the CYP1 CYP2 and CYP3 families publication-title: Curr. Med. Chem. doi: 10.2174/0929867033456855 – start-page: 165 year: 2012 ident: 10.1016/j.tox.2015.02.007_bib0180 article-title: Hydrolytic enzymes – volume: 14 start-page: 55 year: 2013 ident: 10.1016/j.tox.2015.02.007_bib0115 article-title: What is personalized medicine: sharpening a vague term based on a systematic literature review publication-title: BMC Med. Ethics doi: 10.1186/1472-6939-14-55 – volume: 4 start-page: 12 year: 2013 ident: 10.1016/j.tox.2015.02.007_bib0045 article-title: Pharmacogenomics of cytochrome P450 3A4: recent progress toward the missing heritability problem publication-title: Front. Genet. doi: 10.3389/fgene.2013.00012 – volume: 158 start-page: 186 year: 1999 ident: 10.1016/j.tox.2015.02.007_bib0055 article-title: Comparative neurochemical effects of repeated methyl parathion or chlorpyrifos exposures in neonatal and adult rats publication-title: Toxicol. Appl. Pharmacol. doi: 10.1006/taap.1999.8693 – volume: 41 start-page: 844 year: 2013 ident: 10.1016/j.tox.2015.02.007_bib0065 article-title: RNA-sequencing quantification of hepatic ontogeny and tissue distribution of mRNAs of phase II enzymes in mice publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.112.050211 – volume: 269 start-page: 29688 year: 1994 ident: 10.1016/j.tox.2015.02.007_bib0170 article-title: Rat kidney carboxylesterase: cloning, sequencing, cellular localization and relationship to liver hydrolase B publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)43935-X – volume: 53 start-page: 1199 year: 2013 ident: 10.1016/j.tox.2015.02.007_bib0145 article-title: Reduced exposure variability of the CYP3A substrate simvastatin by dose individualization to CYP3A activity publication-title: J. Clin. Pharmacol. doi: 10.1002/jcph.161 – volume: 283 start-page: 9674 year: 2008 ident: 10.1016/j.tox.2015.02.007_bib0150 article-title: Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M709382200 – volume: 42 start-page: 1096 year: 2012 ident: 10.1016/j.tox.2015.02.007_bib0200 article-title: Constitutive expression and phenobarbital modulation of drug metabolizing enzymes and related nuclear receptors in cattle liver and extra-hepatic tissues publication-title: Xenobiotica doi: 10.3109/00498254.2012.694493 – volume: 37 start-page: 1819 year: 2009 ident: 10.1016/j.tox.2015.02.007_bib0215 article-title: Age- and sex-related expression and activity of carboxylesterase 1 and 2 in mouse and human liver publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.109.028209 – volume: 16 start-page: 1207 year: 2009 ident: 10.1016/j.tox.2015.02.007_bib0110 article-title: Human carboxylesterases: an update on CES1, CES2 and CES3 publication-title: Protein Pept. Lett. doi: 10.2174/092986609789071324 – volume: 34 start-page: 389 year: 2006 ident: 10.1016/j.tox.2015.02.007_bib0005 article-title: Ontogeny of hepatic and plasma metabolism of deltamethrin in vitro: role in age-dependent acute neurotoxicity publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.105.007807 – volume: 77 start-page: 238 year: 2009 ident: 10.1016/j.tox.2015.02.007_bib0190 article-title: Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2008.10.005 – volume: 312 start-page: 571 year: 2005 ident: 10.1016/j.tox.2015.02.007_bib0135 article-title: Simultaneous substitution of phenylalaine-305 and aspartate-318 of rat PXR by the corresponding human residues abolishes the ability to transactivate the cytochrome P4503A23 promoter publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.104.074971 – volume: 41 start-page: 2175 year: 2013 ident: 10.1016/j.tox.2015.02.007_bib0095 article-title: RNA-sequencing quantification of hepatic ontogeny of phase-I enzymes in mice publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.113.054635 – volume: 33 start-page: 1603 year: 2005 ident: 10.1016/j.tox.2015.02.007_bib0020 article-title: Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.105.005611 – volume: 8 start-page: 2696 year: 2002 ident: 10.1016/j.tox.2015.02.007_bib0155 article-title: Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells publication-title: Clin. Cancer Res. – volume: 316 start-page: 899 year: 1995 ident: 10.1016/j.tox.2015.02.007_bib0175 article-title: Rat testicular carboxylesterase: cloning sequencing, cellular localization and relationship to liver hydrolase A publication-title: Arch. Biochem. Biophys. doi: 10.1006/abbi.1995.1121 – volume: 315 start-page: 514 year: 1994 ident: 10.1016/j.tox.2015.02.007_bib0070 article-title: Regulation of two rat liver microsomal carboxylesterase isozymes: species differences, tissue distribution and the effects of age sex and xenobiotic treatment of rats publication-title: Arch. Biochem. Biophys. doi: 10.1006/abbi.1994.1532 – volume: 126 start-page: 186 year: 1994 ident: 10.1016/j.tox.2015.02.007_bib0120 article-title: Age-dependent differences in the susceptibility of rats to deltamethrin publication-title: Toxicol. Appl. Pharmacol. doi: 10.1006/taap.1994.1106 – volume: 34 start-page: 880 year: 2006 ident: 10.1016/j.tox.2015.02.007_bib0075 article-title: The human intestinal cytochrome P450 pie publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.105.008672 – volume: 29 start-page: 1548 year: 2001 ident: 10.1016/j.tox.2015.02.007_bib0090 article-title: Cytochrome P450 Involvement in the biotransformation of cisapride and racemic norcisapride in vitro: differential activity of individual human CYP3A isoforms publication-title: Drug Metab. Dispos. – volume: 72 start-page: 686 year: 2007 ident: 10.1016/j.tox.2015.02.007_bib0185 article-title: Interleukin-6 suppresses the expression of carboxylesterases HCE1 and HCE2 through transcriptional repression publication-title: Mol. Pharmacol. doi: 10.1124/mol.107.036889 – volume: 46 start-page: 1319 year: 1997 ident: 10.1016/j.tox.2015.02.007_bib0010 article-title: Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients publication-title: Diabetes doi: 10.2337/diab.46.8.1319 – volume: 203 start-page: 937 year: 2011 ident: 10.1016/j.tox.2015.02.007_bib0125 article-title: Surge in expression of carboxylesterase-1 during the post-natal stage enables a rapid gain of the capacity to activate the anti-influenza prodrug oseltamivir publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiq145 – volume: 22 start-page: 889 year: 1994 ident: 10.1016/j.tox.2015.02.007_bib0040 article-title: Species differences in the induction of hepatic microsomal carboxylesterases caused by dietary exposure to di(2-ethylhexyl) phthalate a peroxisome proliferator publication-title: Drug Metab. Dispos. doi: 10.1016/S0090-9556(25)08432-6 – volume: 1771 start-page: 915 year: 2007 ident: 10.1016/j.tox.2015.02.007_bib0220 article-title: Peroxisome proliferator-activated receptor structures: ligand specificity: molecular switch and interactions with regulators publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbalip.2007.01.007 – volume: 452 start-page: 3 year: 2013 ident: 10.1016/j.tox.2015.02.007_bib0030 article-title: Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2012.05.079 – volume: 84 start-page: 232 year: 2012 ident: 10.1016/j.tox.2015.02.007_bib0160 article-title: Age-related inducibility of carboxylesterases by the antiepileptic agent phenobarbital and implications in drug metabolism and lipid accumulation publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2012.04.002 – volume: 30 start-page: 541 year: 2002 ident: 10.1016/j.tox.2015.02.007_bib0165 article-title: Human and rodent carboxylesterases: immunorelatedness, overlapping substrate specificity, differential sensitivity to serine enzyme inhibitors, and tumor-related expression publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.30.5.541 – volume: 10 start-page: 214 year: 2013 ident: 10.1016/j.tox.2015.02.007_bib0085 article-title: Translational genomics in cancer research: converting profiles into personalized cancer medicine publication-title: Cancer Biol. Med. – volume: 165 start-page: 109 year: 2001 ident: 10.1016/j.tox.2015.02.007_bib0100 article-title: Altered expression of the carboxylesterases ES-4 and ES-10 by peroxisome proliferator chemicals publication-title: Toxicology doi: 10.1016/S0300-483X(01)00416-4 – volume: 8 start-page: e82562 year: 2013 ident: 10.1016/j.tox.2015.02.007_bib0105 article-title: Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy publication-title: PLoS One doi: 10.1371/journal.pone.0082562 – volume: 20 start-page: 163 year: 2006 ident: 10.1016/j.tox.2015.02.007_bib0130 article-title: Pharmacogenetics of irinotecan metabolism and transport: an update publication-title: Toxicol. In Vitro doi: 10.1016/j.tiv.2005.06.045 – volume: 409 start-page: 243 year: 2008 ident: 10.1016/j.tox.2015.02.007_bib0060 article-title: The far and distal enhancers in the CYP3A4 gene coordinates the proximal promoter in responding to the pregnane X receptor similarly but differentially to hepatocyte nuclear factor-4α publication-title: Biochem. J. doi: 10.1042/BJ20070613 – volume: 24 start-page: 762 year: 2004 ident: 10.1016/j.tox.2015.02.007_bib0195 article-title: Towards an understanding of organic anion transporters: structure-function relationships publication-title: Med. Res. Rev. doi: 10.1002/med.20014 – volume: 51 start-page: 75 year: 2010 ident: 10.1016/j.tox.2015.02.007_bib0140 article-title: Normal canine pediatric gastrointestinal ultrasonography publication-title: Vet. Radiol. Ultrasound doi: 10.1111/j.1740-8261.2009.01626.x – volume: 95 start-page: 258 year: 2014 ident: 10.1016/j.tox.2015.02.007_bib0205 article-title: Genetics: epigenetics and regulation of drug metabolizing cytochrome P450 enzymes publication-title: Clin. Pharmacol. Ther. doi: 10.1038/clpt.2013.220 – volume: 11 start-page: 206 year: 2010 ident: 10.1016/j.tox.2015.02.007_bib0035 article-title: Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat publication-title: Cell Metab. doi: 10.1016/j.cmet.2010.02.001 – volume: 28 start-page: 186 year: 2000 ident: 10.1016/j.tox.2015.02.007_bib0210 article-title: Dexamethasone differentially regulates expression of carboxylesterase genes in humans and rats publication-title: Drug Metab. Dispos. doi: 10.1016/S0090-9556(24)15127-6 – volume: 39 start-page: 565 year: 2011 ident: 10.1016/j.tox.2015.02.007_bib0025 article-title: The intestine as an important contributor to prasugrel active metabolite formation in vivo publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.110.035956 – volume: 37 start-page: 2112 year: 2009 ident: 10.1016/j.tox.2015.02.007_bib0080 article-title: MicroRNAs regulate CYP3A4 expression via direct and indirect targeting publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.109.027680 – reference: 11522369 - Toxicology. 2001 Aug 28;165(2-3):109-19 – reference: 7864649 - Arch Biochem Biophys. 1995 Feb 1;316(2):899-908 – reference: 7986099 - Arch Biochem Biophys. 1994 Dec;315(2):513-26 – reference: 12171903 - Clin Cancer Res. 2002 Aug;8(8):2696-700 – reference: 7961958 - J Biol Chem. 1994 Nov 25;269(47):29688-96 – reference: 23939663 - J Clin Pharmacol. 2013 Nov;53(11):1199-204 – reference: 16467132 - Drug Metab Dispos. 2006 May;34(5):880-6 – reference: 21189331 - Drug Metab Dispos. 2011 Apr;39(4):565-70 – reference: 8184428 - Toxicol Appl Pharmacol. 1994 May;126(1):186-90 – reference: 16049125 - Drug Metab Dispos. 2005 Nov;33(11):1603-7 – reference: 16271446 - Toxicol In Vitro. 2006 Mar;20(2):163-75 – reference: 24196843 - Clin Pharmacol Ther. 2014 Mar;95(3):258-61 – reference: 9231657 - Diabetes. 1997 Aug;46(8):1319-27 – reference: 18268015 - J Biol Chem. 2008 Apr 11;283(15):9674-80 – reference: 22766445 - Int J Pharm. 2013 Aug 16;452(1-2):3-7 – reference: 23382457 - Drug Metab Dispos. 2013 Apr;41(4):844-57 – reference: 11717173 - Drug Metab Dispos. 2001 Dec;29(12):1548-54 – reference: 15250040 - Med Res Rev. 2004 Nov;24(6):762-74 – reference: 22513142 - Biochem Pharmacol. 2012 Jul 15;84(2):232-9 – reference: 20166399 - Vet Radiol Ultrasound. 2010 Jan-Feb;51(1):75-8 – reference: 17764444 - Biochem J. 2008 Jan 1;409(1):243-50 – reference: 19487248 - Drug Metab Dispos. 2009 Sep;37(9):1819-25 – reference: 17317294 - Biochim Biophys Acta. 2007 Aug;1771(8):915-25 – reference: 23444277 - Front Genet. 2013 Feb 25;4:12 – reference: 12871098 - Curr Med Chem. 2003 Oct;10(19):1955-72 – reference: 18983829 - Biochem Pharmacol. 2009 Jan 15;77(2):238-47 – reference: 24340040 - PLoS One. 2013;8(12):e82562 – reference: 10640517 - Drug Metab Dispos. 2000 Feb;28(2):186-91 – reference: 22694178 - Xenobiotica. 2012 Nov;42(11):1096-109 – reference: 11950785 - Drug Metab Dispos. 2002 May;30(5):541-7 – reference: 19508181 - Protein Pept Lett. 2009;16(10):1207-14 – reference: 1714639 - Toxicology. 1991;68(1):51-61 – reference: 24359531 - BMC Med Ethics. 2013;14:55 – reference: 7895606 - Drug Metab Dispos. 1994 Nov-Dec;22(6):889-94 – reference: 19581388 - Drug Metab Dispos. 2009 Oct;37(10):2112-7 – reference: 20197053 - Cell Metab. 2010 Mar 3;11(3):206-12 – reference: 21659608 - Oncologist. 2011;16(7):992-1005 – reference: 17537833 - Mol Pharmacol. 2007 Sep;72(3):686-94 – reference: 15367577 - J Pharmacol Exp Ther. 2005 Feb;312(2):571-82 – reference: 21402544 - J Infect Dis. 2011 Apr 1;203(7):937-42 – reference: 24349831 - Cancer Biol Med. 2013 Dec;10(4):214-20 – reference: 16326812 - Drug Metab Dispos. 2006 Mar;34(3):389-97 – reference: 10406933 - Toxicol Appl Pharmacol. 1999 Jul 15;158(2):186-96 – reference: 24080161 - Drug Metab Dispos. 2013 Dec;41(12):2175-86 |
SSID | ssj0002346 |
Score | 2.3066955 |
Snippet | Human carboxylesterase-2 (CES2) and cytochrome P450 3A4 (CYP3A4) are two major drug metabolizing enzymes that play critical roles in hydrolytic and oxidative... Abstract Human carboxylesterase-2 (CES2) and cytochrome P450 3A4 (CYP3A4) are two major drug metabolizing enzymes that play critical roles in hydrolytic and... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 55 |
SubjectTerms | Adult adults Age Amino Acid Sequence biotransformation Carboxylesterase - biosynthesis Carboxylesterase - genetics Carboxylesterases Control cytochrome P-450 Cytochrome P-450 CYP3A - biosynthesis Cytochrome P-450 CYP3A - genetics Cytochrome P450 Cytochromes P450 Drug metabolism Drugs duodenum Duodenum - enzymology Duodenum - growth & development Emergency enzymes Female Gene expression Gene Expression Regulation, Enzymologic genes Human Humans Infant, Newborn jejunum Liver Liver - enzymology Liver - growth & development Male messenger RNA metabolism Molecular Sequence Data Ontogeny Surges therapeutics tissues Toxicology Young Adult |
Title | Ontogenic expression of human carboxylesterase-2 and cytochrome P450 3A4 in liver and duodenum: Postnatal surge and organ-dependent regulation |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0300483X15000438 https://www.clinicalkey.es/playcontent/1-s2.0-S0300483X15000438 https://dx.doi.org/10.1016/j.tox.2015.02.007 https://www.ncbi.nlm.nih.gov/pubmed/25724353 https://www.proquest.com/docview/1664192066 https://www.proquest.com/docview/1732832022 https://www.proquest.com/docview/1770317964 https://www.proquest.com/docview/1846311648 |
Volume | 330 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe27gUJIRhf5WMyEtoDWqhjO07DWzUxFSpGBZvom2UnDhRVydSkUvvCn8DfzPkjnRCsSDxFSc7Kx13uLvbvfofQy6IoUmVKHpWF0BHnXEcKDCXSxpjY8KQcOrqmD-difMnfz5LZHjrtamEsrDL4fu_TnbcORwbhbQ6u5vPBZ8IcH_osTvx61j46oCwTSQ8djN5Nxudbh0xZqNchxM6dzbrFTQfzauu1BXglnrkzvSk83ZR-ujB0dhfdCfkjHvlbvIf2THWIjqeegHpzgi-u66maE3yMp9fU1JtDdNvP0mFffHQf_fxYtTWYEBwy6wCJrXBdYte6D-dqqev1ZuHYFCDcRRSrqsD5pq3zb5bnAE95QjAbcTyv8MJCPJxAsaoLC7F_g20v4MrOEOHG1l-7s66RVNR1323x0nwNPcQeoMuztxen4yh0aIhy-O1pQTRmiShjxomiJQG9F6JkSsdEU0UyldFExynTOWecaqZMPMzTkuki05BqmJQ9RL2qrsxjhCHvo0wLxpjF3Imh1iJTJVEJ2E9amryPSKcYmQf6cttFYyE7nNp3CbqUVpeSUAm67KNX2yFXnrtjlzDttC27olRwoxIiy65B6d8GmSY4gkbGsgFJ-Yex9hHfjvzN3v91wRedIUrwA3ZxR1WmXsGFhLAL-pBB7pCxzEyMQtq2S8Z2NLAFyjtkIGllMfxow2M88l_D9gVDCKCQgrMn__eAT9Etu-exUc9Qr12uzHNI-1p9hPZf_4iPwsdtt5NPXya_AC-WWWQ |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdd-rBBGVv30exTg9GHURNZku1kb6GspGubBZZC3oRkS1tGsEvsQPJP7G_e6cMpY2sGe7VP2Nad707S736H0PuiKDKpDY9MkaqIc64iCYYSKa11rHli-o6u6Wqcjq7551ky20OnbS2MhVUG3-99uvPW4UovzGbvZj7vfSXM8aHP4sSfZ91D-zyB1V4H7Q_PL0bjrUOmLNTrEGL3zmbt4aaDeTXV2gK8Es_cmd0Vnu5KP10YOnuEHob8EQ_9Kz5Ge7o8RMcTT0C9OcHT23qq-gQf48ktNfXmEB34XTrsi4-eoJ9fyqYCE4JLeh0gsSWuDHat-3Aul6pabxaOTQHCXUSxLAucb5oq_255DvCEJwSzIcfzEi8sxMMJFKuqsBD7j9j2Ai7tDhGubf21u-saSUVt990GL_W30EPsKbo--zQ9HUWhQ0OUw7KnAdGYJamJGSeSGgJ6L1LDpIqJopIM5IAmKs6YyjnjVDGp436eGaaKgYJUQ2fsGeqUVamPEIa8jzKVMsYs5i7tK5UOpCEyAfvJjM67iLSKEXmgL7ddNBaixan9EKBLYXUpCBWgyy76sB1y47k7dgnTVtuiLUoFNyogsuwalP1tkK6DI6hFLGqQFH8Yaxfx7cjf7P1fD3zXGqIAP2APd2SpqxU8KE3tgT5kkDtkLDMTo5C27ZKxHQ1sgfIOGUhaWQwLbfiM5_5v2E4whAAKKTh78X8f-BbdH02vLsXl-fjiJXpg73ic1CvUaZYr_RpSwEa9Cb_4L59WWbA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ontogenic+expression+of+human+carboxylesterase-2+and+cytochrome+P450+3A4+in+liver+and+duodenum%3A+Postnatal+surge+and+organ-dependent+regulation&rft.jtitle=Toxicology+%28Amsterdam%29&rft.au=Chen%2C+Yi-Tzai&rft.au=Trzoss%2C+Lynnie&rft.au=Yang%2C+Dongfang&rft.au=Yan%2C+Bingfang&rft.date=2015-04-01&rft.issn=0300-483X&rft.volume=330+p.55-61&rft.spage=55&rft.epage=61&rft_id=info:doi/10.1016%2Fj.tox.2015.02.007&rft.externalDBID=NO_FULL_TEXT |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0300483X%2FS0300483X15X00035%2Fcov150h.gif |